Immunovia AB (FRA:1YR)
€ 0.0338 0.0013 (4%) Market Cap: 8.99 Mil Enterprise Value: 6.59 Mil PE Ratio: 0 PB Ratio: 2.83 GF Score: 42/100

Q2 2023 Immunovia AB (publ) Earnings Call Transcript

Aug 30, 2023 / 01:00PM GMT
Release Date Price: €0.0243 (-16.54%)
Operator

Ladies and gentlemen, welcome to the Immunovia Q2 Interim Report 2023 Conference Call. I'm Alice, Chorus Call operator. I would like to remind you that all participants will be in the listen-only mode and the conference is being recorded.

(Operator Instructions)

The conference will be recorded for publication or broadcast.

At this time, it's my pleasure to hand over to Karin Almqvist, CFO. Please go ahead, madam.

Karin Almqvist Liwendahl;publ;CFO
Immunovia AB

()-

Thank you so much, and good morning and good afternoon to you all. Welcome to this conference call following Immunovia Second Quarter Results. Present here in Lund, in our office is Jeff Borcherding, our CEO; and myself, Karin Almqvist, and I'm the CFO of the company.

Before we start, I'd like to cover some practical aspects. And as you've heard already, the presentation will be followed by a Q&A session. Our operator will guide us on how to -- or guide you on how to post your questions. And this time, you will also be able to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot